Schonfeld Strategic Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-225,733	Closed	-$6.14M	–	2275
2025 Q3	$6.14M	Buy	225,733 +16,182	+8%	+$391K	0.03%	516
2025 Q2	$4.4M	Buy	+209,551	New	+$4.02M	0.03%	605
2024 Q2	–	Sell	-23,354	Closed	-$1.02M	–	2337
2024 Q1	$1.02M	Sell	23,354 -8,353	-26%	-$359K	0.01%	1215
2023 Q4	$1.13M	Sell	31,707 -1,141	-3%	-$34.1K	0.01%	994
2023 Q3	$886K	Sell	32,848 -35,489	-52%	-$900K	0.01%	1054
2023 Q2	$1.61M	Buy	68,337 +19,012	+39%	+$391K	0.01%	823
2023 Q1	$677K	Buy	+49,325	New	+$822K	0.01%	1079

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Schonfeld Strategic Advisors's IDYA Position: Q4 2025 in Review

Schonfeld Strategic Advisors sold out of IDEAYA Biosciences (IDYA) in Q4 2025, closing a stake of 225,733 shares — an estimated $6.14M sold.

Schonfeld Strategic Advisors first reported a position in IDYA in Q1 2023 and held it in 7 quarters. The position peaked at $6.14M in Q3 2025. 246 funds tracked by Wall St. Rank hold IDYA as of Q4 2025.

Schonfeld Strategic Advisors reported no remaining IDEAYA Biosciences position as of Q4 2025 after selling out during the quarter.
Schonfeld Strategic Advisors sold 225,733 IDEAYA Biosciences shares in Q4 2025, an estimated $6.14M.
Schonfeld Strategic Advisors first reported a position in IDEAYA Biosciences in Q1 2023 and held it in 7 quarters.
Schonfeld Strategic Advisors's IDEAYA Biosciences position peaked at $6.14M in Q3 2025.
246 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.